Grosset, K., Needleman, F., Macphee, G. and Grosset, D. (2004) Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Movement Disorders, 19(11), pp. 1370-1374. (doi: 10.1002/mds.20210) (PMID:15389984)
Full text not currently available from Enlighten.
Abstract
Of 99 patients on ergot‐derived dopamine agonists informed about possible long‐term side effects, switching to a nonergot was undertaken in 88 (89%). There were adverse events in 26%. After 11 months, 82% were on their switch agonist and 93% were on any agonist. Switching dopamine agonists is feasible in this population.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | MacPhee, Dr Graeme and Grosset, Professor Donald and Grosset, Dr Katherine |
| Authors: | Grosset, K., Needleman, F., Macphee, G., and Grosset, D. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Journal Name: | Movement Disorders |
| Publisher: | Wiley |
| ISSN: | 0885-3185 |
| ISSN (Online): | 1531-8257 |
| Published Online: | 11 June 2004 |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric